Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 116 publications
Immune checkpoint inhibitor therapy after tumor-infiltrating lymphocytes in unresectable melanoma.
Journal: Journal for immunotherapy of cancer
Published: June 10, 2026
ASO Visual Abstract: The Role of Adjuvant Primary Site Radiotherapy for Patients with Cutaneous Melanoma with Microsatellitosis.
Journal: Annals of surgical oncology
Published: June 01, 2026
Correction: Real-World Outcomes for Patients with Clinically Node-Positive Melanoma Undergoing Neoadjuvant Immunotherapy and Nodal Dissection.
Journal: Annals of surgical oncology
Published: April 24, 2026
Erythrocyte-antibody conjugates to overcome immunotherapy resistance.
Journal: Nature cancer
Published: February 20, 2026
ASO Visual Abstract: International Survey on Evidence for Index Lymph Node Surgery Following Neoadjuvant Systemic Therapy for Stage III Melanoma.
Journal: Annals of surgical oncology
Published: January 23, 2026
The Role of Adjuvant Primary Site Radiotherapy for Cutaneous Melanoma Patients with Microsatellitosis.
Journal: Annals of surgical oncology
Published: January 08, 2026
Investigating Chronic Toxicity, Diet, Patient-Reported Outcomes and the Microbiome in Immunotherapy-Treated Metastatic Melanoma Survivors: A New Frontier.
Journal: Nutrients
Published: October 31, 2025
Editor's Note: Analysis of Immune Signatures in Longitudinal Tumor Samples Yields Insight into Biomarkers of Response and Mechanisms of Resistance to Immune Checkpoint Blockade.
Journal: Cancer discovery
Published: September 17, 2025
Germline variants in cancer susceptibility genes among patients with mucosal melanoma.
Journal: NPJ genomic medicine
Published: September 12, 2025
Intratumoral Sotigalimab with Pembrolizumab Induces Rapid Activation of Antigen-Presenting Cells and Drives Antitumor Responses in Non-injected Tumors in Metastatic Melanoma: A Phase I/II Study.
Journal: Cancer discovery
Published: September 08, 2025
Lymphodepletion, tumor-infiltrating lymphocytes, and high versus low dose IL-2 followed by pembrolizumab in patients with metastatic melanoma.
Journal: Oncoimmunology
Published: August 15, 2025
International Survey on Evidence for Index Lymph Node Surgery After Neoadjuvant Systemic Therapy for Stage III Melanoma.
Journal: Annals of surgical oncology
Published: August 12, 2025
Last Updated: 09/26/2026